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SUMMARY 
Mast cells have for a long time been known to accumulate around tumors (Maltby 
et al., 2009). Studies show that they may be important and sometimes essential in 
tumor angiogenesis, tumor growth and metastasis of tumors (Soucek,	  et	  al., 2007; 
Xiang et al., 2010). In an expression array study (Wensman et al, submitted 
manuscript) performed on mouse mast cells exposed to tumor conditioned 
medium, the gene 4-1BB was among the most up-regulated genes compared to 
control medium. 4-1BB codes for a membrane receptor protein of the tumor 
necrosis factor superfamily and has been shown to be important in T cell 
regulation in tumor diseases. This study was performed to investigate if human 
mast cells up-regulate 4-1BB when they get exposed to tumor conditioned 
medium. Two human mast cell lines were used: HMC-1 and Lad-2. When 
comparing them, Lad-2 had a more clear response to tumor conditioned medium 
and showed higher expression of 4-1BB. Two different tumor cell lines were used 
for studying the mast cell response to tumors: The thyroid carcinoma cell line 
Kat-4 and the melanoma cell line SK-MEL-30. Using Kat-4 to stimulate the 
human mast cells led to an up-regulated gene expression of 4-1BB while the use 
of SK-MEL-30 as a stimulant did not. The gene expression of 4-1BB in Lad-2 
peaked after four hours of stimulation with serum free medium conditioned with 
Kat-4 cells. After twenty-four hours the gene expression of 4-1BB decreased, 
which is a pattern that followed what Nishimoto Et al. showed in 2005 where 
expression of 4-1BB was investigated in mouse mast cells. Protein expression of 
4-1BB was measured after zero, four and twenty-four hours. No up-regulated 
protein expression of 4-1BB was observed in neither HMC-1 cells nor Lad-2 cells 
after stimulation with tumor cell line conditioned medium, however there was an 
increase of 4-1BB protein in response to calcium ionophore. In this study human 
mast cells responded to stimulation of tumor factors by significantly up-regulate 
the gene 4-1BB. Further, a correlation between expression of 4-1BB mRNA and 
4-1BB protein was not observed.  
SAMMANFATTNING 
Det har länge varit känt att mastceller ansamlas runt tumörer (Maltby et al., 2009). 
Studier visar att de kan vara viktiga och ibland nödvändiga för kärlnybildning, 
tumörtillväxt och tumörspridning (Soucek,	  et	  al., 2007; Xiang et al., 2010). Vid ett 
experiment (Wensman et al, insänt manuskript) med mastceller från mus som 
inkuberades i tumörstimulerat medium visade sig 4-1BB vara en av de gener som 
uppreglerades mest jämfört med kontrollmedium. 4-1BB är ett membranprotein i 
tumörnekrosfaktorsuperfamiljen som kodar för en receptor viktig i t-cellsreglering 
vid tumörsjukdom. Den här studien syftar till att undersöka huruvida humana 
mastceller uppreglerar 4-1BB när de exponeras för tumörkonditionerat medium. 
Två humana mastcellinjer användes: HMC-1 och Lad-2. När de jämfördes visade 
Lad-2 en tydligare respons på tumörkonditionerat medium och ett högre uttryck 
av 4-1BB. Två olika tumörcellinjer användes: Thyroideacarcinomcellinjen Kat-4 
och melanomcellinjen SK-MEL-30. Genuttrycket av 4-1BB var som högst hos 
Lad-2-celler efter fyra timmars stimulering i serumfritt medium konditionerat med 
Kat-4-celler.  
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Efter tjugofyra timmar sjönk genuttrycket av 4-1BB vilket följer mönstret som 
bl.a. ses i en studie av Nishimoto Et al. från 2005 där uttrycket av 4-1BB hos 
musmastceller studerades. Proteinuttryck av 4-1BB mättes efter noll, fyra och 
tjugofyra timmar. Inget uppreglerat proteinutryck av 4-1BB observerades i vare 
sig HMC-1-celler eller Lad-2-celler efter stimulering med 
tumörcellinjekonditionerat medium, däremot noterades en ökning av 4-1BB 
protein som respons på kalciumjonofor. I denna studie svarade humana mastceller 
på stimulering med faktorer utsöndrade från tumörceller genom att signifikant 
uppreglera genen 4-1BB. Däremot observerades ingen korrelation mellan uttryck 
av 4-1BB mRNA och 4-1BB protein. 
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INTRODUCTION 
Mast cells 
The mast cell is a type of myeloid cell. Other myeloid cells are erythrocytes, 
thrombocytes, basophils, neutrophils, eosinophils and macrophages. Mast cells 
have granules, which contain e.g. histamine and tryptase. Histamine is an amine 
important in allergic reactions. Tryptase is a protease important in inflammation 
and anaphylaxis. Mast cells degranulate when they get activated. There are three 
ways to activate them: by activated complement proteins, cross-linking of 
Immunoglobulin E (IgE) receptors (FcεRI) or by direct injury to the cell. Besides 
being important in allergic reactions and anaphylaxis, mast cells may have an 
important role in defense against pathogens and tumors (Grewal, 2009).  
Mast cells and tumors 
Mast cells accumulate around tumors (Maltby et al., 2009). For instance, twice as 
many mast cells per unit area are seen in primary melanomas than in common 
acquired nevi (moles) (Guidolin et al., 2005). There are also indications that mast 
cells influence tumor growth (Maltby et al., 2009) and that they can either 
promote (Carlini et al., 2010) or inhibit (Oldford et al., 2010) the tumor. Mast 
cells accumulate in the space between healthy and malignant tissue, the 
peritumoral area, also called the invasive front, the area of tumor expansion. In 
breast cancer, mast cell density is higher in peritumoral tissue than in normal 
breast tissue (Xiang et al., 2010). Mast cells are often found close to blood vessels 
(Guidolin et al., 2005) and since they express many pro-angiogenic compounds 
they may be important in tumor angiogenesis (Sawatsubashi et al., 2000). Several 
studies have looked into the correlation between mast cells and vessel count. For 
example, in lung carcinomas it has been shown that the density of mast cells and 
micro vessels is higher peritumorally than intratumorally (Carlini et al., 2010). 
The blood vessel density was almost six times higher in primary melanomas than 
in common acquired nevi (Guidolin et al., 2005).  
There are also indications that mast cell and vessel density correlate with the 
aggressiveness, the grading, of the tumor. In stage IV gastric carcinomas the 
density of mast cells as well as blood vessels is higher than in stage I, II and III 
gastric carcinomas (Ribatti et al., 2010). A progressive increase in vessel and mast 
cell density is seen between stage I and IV. Mast cell density is higher in grade III 
breast cancers than in grade I and II breast cancers. In breast cancers with lymph 
node metastasis mast cell density is higher compared to breast cancers without 
lymph node metastasis. These studies support the theory that mast cells may have 
a part in tumor angiogenesis and tumor growth. One way for a cell to inhibit 
tumor growth is by immune activation/suppression. Activated T cells can for 
example have a part in activity against tumors (Grewal, 2009). 
These influences on tumor growth are of great interest from a medical viewpoint. 
This is mainly because greater insight into the different mechanisms involved may 
provide knowledge leading to the development of new immunotherapeutic drugs 
against cancer.  
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In veterinary medicine mast cells in the context of tumors are generally associated 
with mastocytomas. However, this study is focusing on mast cells’ up-regulation 
of a specific gene, 4-1BB, after stimulation by a tumor conditioned medium.  
Further, in vivo experiments have shown that mast cells accumulate around 
tumors before angiogenesis starts (Crivellato et al., 2008). An in vivo experiment 
of epithelial carcinogenesis showed that mast cells might participate in an early 
stage of tumor development (Coussens et al., 1999). Tumor progression correlated 
with up-regulation of pro-angiogenic coding genes. An in vivo study of pancreatic 
B-cell tumors showed that fast recruitment of mast cells by activation of Myc (a 
pleiotropic transcription factor, commonly overexpressed in human tumors, that 
impacts on for e.g. angiogenesis and remodelling of extracellular matrix) is 
crucial for tumor growth (Soucek,	   et	   al., 2007). There are at this point many 
studies that have addressed the question if mast cells have an effect of the 
outcome of a tumor disease. Most of the studies have used clinical material and 
focused on correlations between mast cell densities, location and prognosis. 
However, so far there have not been so many mechanisms identified and thereby 
it is relatively unknown how mast cells affect tumor growth and that calls for 
further studies.   
4-1BB 
4-1BB belongs to the tumor necrosis factor (TNF) superfamily, a group important 
in inflammation and immune regulation. TNFs are cytokines produced by e.g. 
macrophages and T cells. TNF-α is an acute phase protein, which together with 
other cytokines is important in recruiting immune cells to get a fast 
immunological response against pathogens. Lymphotoxin, formerly called TNF-β, 
inhibits tumor growth.  
4-1BB is a transmembrane protein expressed on the cell surface (Schwarz, 2005). 
4-1BB mRNA was first detected in cytotoxic T cells and T helper cells (Kwon 
and Weissman, 1989). By confocal laser microscopy the protein was shown to be 
expressed on the cell surface of cytotoxic T cells and T helper cells (Yunle W et 
al., 2003). See figure 1. The expression is concentrated to approximately one third 
of the cell membrane. See figure 1.   
Studies have shown that up-regulation of the 4-1BB gene in T cells results in 
tumor inhibition (Miller et al., 2002; Murillo et al., 2008). Mast cells are also 
known to express 4-1BB (Nishimoto et al., 2005). By binding an agonistic 4-1BB 
Ab to 4-1BB, a cell can get either stimulated or regulated (Grewal, 2009). 
Agonistic 4-1BB Ab can stimulate Natural killer cells and T cells. These activated 
cells may protect against tumors or virus. See figure 2. 
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When 4-1BB-/- and 4-1BBL-/- mast cells get stimulated through FcεRI they have 
defects in degranulation and cytokine production. Hence, 4-1BB and 4-1BBL may 
costimulate mast cells as they costimulate T cells, and agonistic 4-1BB Ab may 
thus be able to stimulate mast cells as they stimulate T cells and Natural killer 
cells. 4-1BBL, a transmembrane protein (Schwarz, 2005) binding to 4-1BB can 
activate T cells, which leads to expansion of tumor reactive T cells (Grewal, 
2009). It is therefore of interest to investigate the expression of 4-1BB in mast 
cells when they are exposed to factors secreted by tumor cells. Very little is 
known about 4-1BB’s expression in mast cells. A study performed by Nishimoto 
et al. in 2005 showed that naive mast cells do not express detectable mRNA levels 
of 4-1BB. After sensitization over night with IgE, 4-1BB was induced. If no more 
stimulation was done, the levels of 4-1BB decreased during the incubation period. 
If stimulated with agonistic rat anti-4-1BB monoclonal antibody (mAb) an 
increase in mRNA-levels of 4-1BB was seen after 8 hours and then the levels 
decreased over the 48 hours incubation. Protein expression of 4-1BB reached its 
highest level after 8 hours sensitization with IgE, and after 12 hours the 
expression decreased.  
 
Figure 1. 4-1BB protein is expressed on parts of the cell surface of T cells (Yunle et al., 
2003; illustration after Yunle et al., 2003). 
 
Figure 2. Stimulation of a mast cell by agonistic 4-1BB Ab leads to cell activation and 
protection against tumors and virus (Grewal, 2009; illustration after Grewal, 2009).  
4-1BB and tumor rejection     
Treatment with anti-4-1BB in mice with fibrosarcomas often resulted in total 
tumor rejection or in significant reduction of tumor growth and reduced tumor 
size (Miller et al., 2002).  
Anti-4-1BB 
4-1BB 
Protection against tumors or virus 
4-1BB 
protein 
Cell membrane 
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Cytotoxic T cells mediated tumor rejection after treatment with anti-4-1BB and 
this also resulted in long-lasting tumor-specific memory. Anti-4-1BB was used on 
six tumor models and caused a high rate of rejection in four of them. In mice, anti-
4-1BB is effective against HOPC, a myeloma model, NS0 myelomas and 5TGM1, 
a mouse myeloma cell line reminiscent of human multiple myeloma (Murillo et 
al., 2008). It gives longer time of survival and a long-lasting anti-tumor immunity. 
4-1BB is not expressed on the cell membrane of HOPC, NS0 or 5TGM1. Tumor 
rejection by anti-4-1BB requires natural killer cells, Cytotoxic T cells and IFN-γ. 
A phase II clinical trial study, NCT00612664, of anti-4-1BB for treatment of 
melanomas has recently been carried out, no data has yet been published (U.S. 
National Institutes of Health [online],  2010). Mice with an established 
subcutaneous B16 (B16-F10, a melanoma cell line) tumor had a lower rate of 
tumor growth when treated with Tyrosinase-related protein 2 (pTRP2)-specific 
allo-restricted cytotoxic T Cells compared to untreated mice or mice treated with 
naive B6 Cytotoxic T cells (Lu et al., 2008; Lu et al., 2009). 4-1BBL is one of the 
components in pTRP2-specific allo-restricted CTLs. The mice lived longer than 
the other mice, over 60 days compared to up to 27 days. When B16 tumor cells 
were given intravenously to provoke the formation of lung metastasis, the group 
treated with pTRP2-specific allo-restricted CTLs had a lower rate of metastases 
than the untreated mice, mice treated with naive B6 Cytotoxic T cells or pMut1-
specific allo-restricted CTLs (a control peptide). These results indicate that anti-4-
1BB can have a part in rejection of tumors or reduction of tumor size. It can also 
lead to longer time of survival and a long-lasting anti-tumor immunity. This, 
combined with the phase II clinical trial study on anti-4-1BB, is a strong indicator 
that anti-4-1BB can be important in immunotherapy against cancer in the future. 
4-1BBL may affect tumor growth, tumor metastasis and time of survival in mice 
with melanomas. It is interesting that it seems to have effects both on 
subcutaneous tumors and tumor metastasis. If a subcutaneous tumor has a lower 
rate of growth it can be expected to lead to a longer time of survival and also a 
lower rate of tumor metastasis. In these studies it is shown that 4-1BBL also may 
give a direct protection against metastasis when tumor cells are trying to spread 
through the blood. 
Aim of study 
The aim of the study was to investigate if human mast cells up-regulate 4-1BB 
when exposed to tumor conditioned medium. In mouse mast cells exposed to 
tumor conditioned medium it has been shown that the gene 4-1BB is among the 
most up-regulated genes and responds with a 13-fold increase of mRNA 
compared to control medium (Wensman et al, submitted manuscript). 4-1BB is 
known to be involved in defence against tumors, which makes it an interesting 
gene and that is the main reason 4-1BB was chosen for this study. Today there is 
not much knowledge about the mechanisms behind mast cells’ effect on tumors. 
In this study we wanted to investigate both gene and protein expression of 4-1BB, 
in the protein expression we were also interested in the expression pattern. 
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Study setup 
To investigate if mast cells up-regulate 4-1BB when they get exposed to tumors a 
model for this was used. HMC-1 and Lad-2 cells originating from a human 
mastocytoma and a mast cell sarcoma/leukemia respectively, served as mast cell 
models. A study by Guhl Et al. in 2010 shows that HMC-1 cells are immature 
tumor mast cells which makes them very different from peripheral mast cell 
whereas Lad-2 cells are more differentiated and therefore are more alike 
peripheral mast cells. Tumor cells secrete a lot of substances to their micro 
environment to help them expand, infiltrate and metastasize. These substances are 
thought to influence the mast cells found in or close to the tumor. Medium where 
tumor cells were cultured, called tumor conditioned medium, contains these 
substances and when mast cells are incubated in this medium they may up-
regulate 4-1BB. Tumor conditioned medium was made by allowing Kat-4, a 
thyroid carcinoma cell line, or SK-MEL-30, a melanoma cell line, to grow in a 
fresh medium for two to three days, depending on expansion rate. The media were 
then filtrated, collected and stored at – 200 C.   
 
To study if human mast cells up-regulate 4-1BB when exposed to tumor 
conditioned medium three methods were used. Real time-PCR was used to study 
gene expression of 4-1BB. Protein expression was studied by two methods: 
fluorescence activated cell sorting (FACS) and immunohistology. In all three 
methods the same incubation times were used: zero hours, four hours and twenty-
four hours. Samples for RNA and protein expression were taken at the same time, 
the samples for first and second Real time-PCR were taken when sampling for the 
FACS experiments and the samples for the third Real time-PCR were collected 
when sampling for the second immunohistology experiment. In all three methods 
calcium ionophore was used as a positive control, it activates the mast cell which 
will express 4-1BB. In immunohistology human spleen was also used as a 
positive control, which was used since it contains cells that express 4-1BB.  
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MATERIAL AND METHODS 
Cell cultures 
The human cell lines used in this study 
The HMC-1 cell line was chosen due to their fast proliferation rate. They are 
however quite unlike peripheral mast cells since they are immature (Guhl Et al., 
2010). The cells were cultured in IMDM, from SIGMA, with 10% Fetal Bovine 
Serum (FBS), 5% 200 mM L-glutamin (GIBCO), 5% PEST (6 mg/ml resp. 5 
mg/ml, SVA 992450) and 0,05% α-thioglycerol. The Lad-2 cell line was not used 
in the early experiments due to the cell’s slow proliferation rate and the difficulty 
in culturing. Lad-2 cells resemble peripheral mast cells since they are more 
differentiated then HMC-1 cells (Guhl Et al., 2010). The cells were cultured in 
Stem Pro® - 34 SFM (Serum free medium for Hematopoetic Stem cells), with 
Nutr sup, GLN and 5% PEST (6 mg/ml resp. 5 mg/ml, SVA 992450). 
Kat-4 cells originate from a poorly differentiated human thyroid carcinoma 
(Husmark Et. Al., 2002). The proliferation rate is high and they show a multi-
layered growth. SK-MEL-30 originate from a human melanoma (Romano et al., 
2009). This cell line is of interest since mast cells often are found around 
melanomas (Guidolin et al., 2005). Kat-4 cells and SK-MEL-30 cells were 
cultured in RPMI 1640 + GlutaMAXTM-I, from GIBCO, with 50% FBS, 5% L-
glutamine (GIBCO) and 5% PEST (6 mg/ml respective 5 mg/ml, SVA 992450).  
Real time-PCR 
RNA was purified from cultured cells with NucleoSpin® RNA II (Macherey-
Nagel) according to instructions from the manufacturer. The cells were lysed. To 
reduce viscosity and to clear the lysate, the samples were filtrated. To adjust RNA 
binding conditions, 70% RNase-free ethanol was added to the lysates. To bind 
RNA each mixed lysate was loaded to a column. To desalt and dry silica 
membranes Membrane Desalting Buffer was added to each column. To digest 
DNA, DNase reaction buffer (prepared by mixing 10 µl reconstituted rDNase and 
90 µl Reaction Buffer for rDNase (Macherey-Nagel) for each isolation) were 
applied onto the silica membrane and then the samples were incubated in room 
temperature for 15 minutes. To wash and dry silica membranes the membranes 
were washed three times with buffers. To elute RNA, RNase-free water was 
added to each column.  
For synthesis of cDNA from total RNA, as templates, random hexamers (50 
µg/µl; Invitrogen) and dNTPs (2 mM) were mixed for each sample. The samples 
were heated to 65ºC for 5 minutes and then put on ice and chilled for 2 minutes. 5 
x strand buffer and 0,1M DTT were added to each sample and then the samples 
were incubated for 2 minutes at 25ºC. Superscript II (Invitrogen), on ice, was 
added to each sample and then the samples were incubated for 10 minutes at 25ºC. 
After that the samples were incubated at 42ºC for 50 minutes and then at 700C for 
15 minutes. 
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Real-time PCR, a quantitative PCR, is used to measure amounts of cDNA or 
mRNA in a sample (Molecular station, 2005-2010). It is commonly used to 
determine a gene's expression by measuring the amount of mRNA in a sample. It 
can for example be used for comparing gene expression between control and 
disease samples.  
Primer efficiency for human 4-1BB’s primer pair (Integrated DNA Technologies; 
forward primer: 5´-TGC TTG TGA ATG GGA CGA AGG AGA-3´ and reverse 
primer: 5´-AGA AAC GGA GCG TGA GGA AGA ACA-3´) was determined 
from the CT-values from three different dilutions of cDNA. The CT-values were 
plotted for each dilution against log concentration to calculate efficiency, using 
this equation: 10^(1/slope) 1. A mastermix containing SYBR Mix (Invitrogen), 
Primer mix (10 µM), referens dye (Invitrogen) and RNase-free water was used. 
Technical duplicates were used in all experiments. Human GAPDH served as a 
housekeeping gene. Forward primer: 5´-TCG ACA GTC AGC CGC ATC TTC 
TTT-3 and reverse primer: 5´-ACC AAA TCG GTT GAC TCC GAC CTT-3´.  
The Real time-PCR cycling conditions were 2 minutes at 500 C followed by 10 
minutes at 950C. Then the samples were cycled 40 times at 950 C (denaturation) 
for 15 seconds, at 600C (annealing) for 1 minute. ABI Prism 7900 HT using iQ 
collected data which was analyzed with SDS software. The results were calculated 
according to User Bulletin #2: ABI PRISM 770 Sequence Detection System (P7N 
4303859; Applied Biosystems), a comparative CT-method.   
FACS  
Extracellular staining 
To reduce unspecific binding, the cells were resuspended in an Fc-block mixture 
containing 0,5% Fc-block (AbCam) and 3% Bovine serum albumine 
(BSA)/Phosphate-buffered saline (PBS). Then the samples were incubated on ice 
for 15 minutes. The cells were either incubated with a mouse anti-4-1BB mAb 
(AbCam), a mouse IgG polyclonal Antibody ((pAb); AbCam) or 3% BSA/PBS on 
ice in the dark for 30 minutes. The cells were washed three times with 10% 
FBS/PBS. Then 10% FBS/PBS was added to each sample. A FACScan (Becton 
and Dickinson) was used for cell acquisition and Cell Quest software was used for 
data analyses. 
Intracellular staining 
The cells were washed with 0,5% BSA/2mM ethylenediaminetetraacetic acid 
(EDTA)/PBS. Then the cells were resuspended with PBS and 4% formaldehyde 
and incubated in room temperature for 20 minutes. The cells were washed two 
times with 1% BSA/0,09% Na azid/PBS. Then the cells were resuspended with 
0,5% saponin in 1% BSA/0,09% Na azide/PBS and incubated on ice for 10 
minutes. The cells were washed with 1% BSA/0,09% Na azide/PBS two times. To 
reduce unspecific binding, the cells were resuspended in Fc-block mixture 
containing 0,5% Fc-block and 99,5% 0,5% BSA/2mM EDTA/PBS. Then the 
samples were incubated on ice for 15 minutes.  
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The cells were incubated either with a mouse anti-4-1BB mAb, a mouse IgG pAb 
or 0,5% BSA/2mM EDTA/PBS on ice in the dark for 30 minutes. The cells were 
washed two times with 1% BSA/0,09% Na azid/PBS. Then 1% 
Foramaldehyde/PBS was added to the cells.  
Immunohistology 
The cytospin specimens were centrifuged for 3 minutes at 800 or 1000 rounds per 
minute (rpm). After that they were put in room temperature for one hour to dry 
and then they were stored at -20°C.  
Paraffin sections were deparaffinized and rehydrated. The cytospin specimens 
were fixated in 4% buffered formaldehyde for 10 minutes and then rehydrated. 
This fixation resembles the fixation used for the paraffin sections. All specimens, 
paraffin sections and cytospin specimens, were put in a bath with antigen retreival 
buffer (PT Mudule buffer (Labvision)), and were boiled at 1250 C for 4 minutes 
followed by 900 C for 4 minutes in a pressure boiler (Pascal, DakoCytomation). 
They were then washed three times in Tris-buffered saline-Tween 20 (TBS-T). 
The specimens were covered with a peroxidasblock (Dako) and incubated in room 
temperature for 5 minutes. They were washed three times with TBS-T. To reduce 
unspecific binding, goat serum (1:50 or 1:10 + 0,5% BSA) was added to each 
specimen and they were then incubated in room temperature for one hour. Goat 
serum was chosen since the secondary antibody was made from goat. The 
specimens were then incubated with a primary antibody, rabbit anti-4-1BB mAb 
(AbCam) or rabbit Ig polyclonal antibody (pAb) (isolated from serum, Dako), or 
TBS-T over night at 40C. Rabbit Ig pAb served as negative control since the 4-
1BB was a polyclonal rabbit antibody. Mast cells are known to bind antibodies 
unspecifically and isotype control antibodies are important for the evaluation of 
the results. If binding pattern of rabbit Ig pAb are compared to binding pattern of 
rabbit anti-4-1BB mAb the specific binding of rabbit anti-4-1BB mAb can be 
determined. TBS-T served as negative control to illustrate the specimens without 
a primary antibody binding to the cells. Paraffin sections from human spleen 
served as positive controls. Rabbit anti-4-1BB mAb was diluted 1:500 and rabbit 
Ig pAb 1:1000. The specimens were rinsed with TBS-T and then washed three 
times with TBS-T. Then peroxidase marked polymer (secondary antibody, Dako) 
was added to each specimen and they were incubated in room temperature for 30 
minutes. After that the specimens were rinsed with TBS-T and then washed three 
times with TBS-T. Substrate chromogen solution (1% Dab (chromogen)/99% 
substrate buffer, Dako) was added to each specimen and they were then incubated 
in room temperature for one minute. The specimens were washed in deionized 
water and bathed in Mayer (water based hematoxylin) for 30 seconds. The 
specimens were washed in deionized water and then they were washed for 10 
minutes in slowly pouring tap water. Dehydration of the specimens was 
performed by bathing them in ethanol and xylene. The specimens were mounted 
with pertex. A Leica DMLA microscope was used and photos were taken with 
Leica DC 200. For optimizing the photos, Photoshop was used.    
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RESULTS  
To investigate the 4-1BB protein expression in human mast cells exposed to 
tumor conditioned medium, a FACS experiment with HMC-1 cells was 
performed. HMC-1 cells were incubated with medium conditioned with Kat-4 
cells or control medium. The experiment was performed with cell surface 
staining. No differences were seen either between conditioned medium and 
control medium or between the 4-1BB antibody and the isotype control antibody. 
Figure 3 shows protein expression of 4-1BB and IgG control after twenty-four 
hours in HMC-1 cells. Since no difference was seen between antibodies or media, 
a new experiment with the same antibodies but with medium conditioned with 
SK-MEL-30 cells instead of medium conditioned with Kat-4. The reason for 
keeping the antibodies is that since they may work it is not wise to change both 
medium stimulant and antibodies at the same time. The experiment with SK-
MEL-30 conditioned medium was also performed with cell surface staining. The 
result was the same, no differences between conditioned medium and control 
medium or between the 4-1BB antibody and the isotype control antibody. With 
this method even a low protein expression could be found. If the mast cells do not 
express 4-1BB on their cell surface the reason for not finding it can be that they 
are expressed intracellularly. In 2005 Nishimoto et al. showed that mouse mast 
cells express 4-1BB on their cell surface. It has not been shown that human mast 
cells express 4-1BB on their cell surface but likely they do. If human mast cells do 
not express 4-1BB on their cell surface, the protein expression can be found in a 
FACS experiment with intracellular staining. The next FACS experiment was 
therefore carried out with intracellular staining. Since Lad-2 cells is a better model 
for peripheral mast cells than HMC-1 cells they were used instead of HMC-1 
cells. 
Immunohistology was also used to study human mast cells’ protein expression of 
4-1BB. By using immunohistology protein expression pattern and localisation of 
the protein can be observed. In the first immunohistology experiment, HMC-1 
cells were either incubated in medium conditioned with Kat-4 cells or control 
medium. Human spleen served as a positive control. Used antibodies were rabbit 
anti-4-1BB pAb and rabbit isotype control IgG pAb. TBS-T (no primary 
antibody) served as a negative control. In human spleen 4-1BB was expressed: 
there were some strongly positive cells, many moderately positive and some 
negative cells. No differences were seen between cytospin specimens incubated in 
medium conditioned with Kat-4 cells for zero and four hours. The rabbit IgG pAb 
did not work as a negative control since the binding pattern was too unspecific. 
That made it hard to find the specific expression of 4-1BB. See figure 4. Since 
HMC-1 cells differ quite much from peripheral mast cells, the next 
immunohistology experiment was carried out with Lad-2 cells that are more like 
peripheral mast cells. In the next immunohistology experiment another rabbit Ig 
pAb was tested but there was not enough time to find the optimal dilution of it so 
it did not work as a negative control. 
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Figure 3. FACS, cell surface staining of HMC-1 cells. A. Expression of 4-1BB in cells 
incubated for twenty-four hours either in medium with 10% FBS (black) or medium with 
10% FBS conditioned with Kat-4 cells (green). No significant difference in expression of 
4-1BB was seen between mediums. B. Isotype control antibody binding to cells incubated 
for twenty-fours hours in medium with 10% FBS (black) and medium with 10% FBS 
conditioned with Kat-4 cells (green). No significant difference in expression of IgG was 
seen between mediums.  
A FACS experiment, using intracellular staining, was performed with Lad-2 cells 
incubated with mouse anti-4-1BB mAb or mouse isotype control IgG mAb, either 
in medium with 10% FBS conditioned with SK-MEL-30 cells or 10% FBS, 
medium as negative control. Serum free medium or serum free medium with 
calcium ionophore were also used as controls. Calcium ionophore was added as a 
positive control to trigger 4-1BB gene expression by increasing the intracellular 
Ca2+ levels. After twenty-four hours incubation a shift in Lad-2 cells incubated 
with mouse anti-4-1BB mAb in serum free medium with calcium ionophore was 
seen. There were also higher amount of isotype control antibody bound to the 
Lad-2 cells grown in serum free medium. No other differences between Kat-4 
conditioned or control mediums or the 4-1BB and the isotype control antibody 
were seen. Figure 5 shows expression of 4-1BB and IgG after twenty-four hours 
in Lad-2 cells either incubated in medium with 10 % FBS, medium with 10% FBS 
conditioned with SK-MEL-30 cells, serum free medium or serum free medium 
with calcium ionophore. 
To investigate the gene expression of 4-1BB in human mast cells, real time-PCR 
was used. In the first experiment HMC-1 cells were either incubated in medium 
conditioned with Kat-4 or SK-MEL-30 cells. 4-1BB was up-regulated in HMC-1 
cells incubated for four hours in medium conditioned with Kat-4 cells but not in 
HMC-1 cells incubated in medium conditioned with SK-MEL-30 cells. No 
difference was seen between HMC-1 cells incubated in control medium (Figure 
6A). This indicates that Kat-4 cells can stimulate mast cells to express 4-1BB.  
A B 
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Since this result was provided first after collecting cells for the FACS 
experiments, SK-MEL-30 cells were chosen as medium stimulants for the next 
Real time-PCR experiment. In the next experiment Lad-2 cells were used since 
they are more alike peripheral mast cells than HMC-1 cells are. Calcium 
ionophore was used as positive control to establish that the mast cells can express 
4-1BB.  
In the second Real time-PCR experiment, Lad-2 cells were either incubated in 
medium conditioned with SK-MEL-30 or its corresponding control medium, 
serum free medium or serum free medium with calcium ionophore. 4-1BB was 
up-regulated in Lad-2 cells incubated for four hours in medium with 10% FBS 
and in medium with 10% FBS conditioned with SK-MEL-30 cells. This could 
indicate a serum effect on Lad-2 cells, which are usually cultured in serum free 
medium. 
 
 
 
 
 
 
 
  
 
    
   
 
 
 
 
Figure 4A. Immunohistology. Human spleen incubated with rabbit anti-4-1BB mAb. 
Positive cells, black arrows, with brown cytoplasma. B. HMC-1 cells incubated for zero 
hours in medium conditioned with Kat-4 cells, cytospin specimen incubated  with rabbit 
anti-4-1BB mAb. No distinctly positive cells. C. HMC-1 cells incubated for four hours in 
medium conditioned with Kat-4 cells, cytospin specimen incubated with rabbit anti-4-
1BB mAb. No distinctly positive cells. 
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Figure 5. FACS, Intracellular staining of Lad-2 cells. A. Expression of 4-1BB in cells 
incubated for twenty-four hours in serum free medium (pink), medium with calcium 
ionophore (clear blue), medium with 10% FBS (yellow) and medium with 10% FBS 
conditioned with Kat-4 cells (dark blue). A shift in Lad-2 cells incubated in serum free 
medium with calcium ionophore was seen (clear blue). B. Isotype control antibody 
binding to cells incubated for twenty-four hours in serum free medium (pink), serum free 
medium with calcium ionophore (clear blue), medium with 10% FBS (yellow) and 
medium with 10% FBS conditioned with Kat-4 cells (dark blue). No significant 
differences in expression of IgG were seen between mediums.  
Lad-2 cells incubated in serum free medium with calcium ionophore up-regulated 
their gene expression of 4-1BB after twenty-four hours, which means human mast 
cells most likely express 4-1BB and calcium ionophore works as a positive 
control (Figure 6B). Since Lad-2 cells stimulated with SK-MEL-30 do not express 
4-1BB in this experiment, Lad-2 cells stimulated with Kat-4 cells were used in the 
next experiment. Lad-2 cells are normally cultured in serum free medium and in 
the next experiment only serum free medium were used. At time zero, no gene up-
regulation should be seen and, because of that, only Lad-2 cells incubated in 
serum free medium were used at that time point in the next experiment.  
In the third Real time-PCR experiment, Lad-2 cells were either incubated in 
serum free medium, serum free medium conditioned with Kat-4 cells or serum 
free medium with calcium ionophore. At time zero, no up-regulation at the mRNA 
level was seen. Calcium ionophore served as a positive control. A t-test showed a 
statistically significant difference between Lad-2 cells incubated for four hours in 
serum free medium and Lad-2 cells incubated for four hours in serum free 
medium conditioned with Kat-4 cells. In this experiment biological duplicates 
were used (Figure 6C). This experiment shows that human mast cells have an up-
regulated gene expression of 4-1BB when they are exposed to medium 
conditioned with Kat-4 cells. A significant up-regulation of 4-1BB is seen after 
four hours. After twenty-four hours the gene expression has decreased, in 
agreement with the results from a study by Nishimoto et al. in 2005.  
A B A 
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Figure 6. A. An up-regulation of 4-1BB in HMC-1 cells incubated in medium with 10% 
FBS is seen. The reason for using medium with 10% FBS two times in the experiment is 
that the cells were collected at two different time points and each medium with 10% FBS 
is a control to respective conditioned medium. B. The up-regulation of 4-1BB in Lad-2 
cells incubated in medium with 10% FBS and in medium with 10% FBS conditioned with 
SK-MEL-30 cells is probably a serum effect since Lad-2 cells usually are cultured in 
serum free medium. Calcium ionophore serves as positive control. C. A significant 
difference in expression of 4-1BB is found between Lad-2 cells incubated with mouse 
anti-4-1BB mAb for four hours in serum free medium and in serum free medium 
conditioned with Kat-4 cells. Serum free medium serves as a negative control and serum 
free medium with calcium ionophore serves as a positive control.  
A 
B 
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An immunohistology experiment was carried out with Lad-2 cells either incubated 
in serum free medium, serum free medium conditioned with Kat-4 cells or serum 
free medium with calcium ionophore. Human spleen served as a positive control. 
The antibodies used were: rabbit anti-4-1BB pAb and rabbit IgG pAb (served as a 
negative control). TBS-T (no primary antibody) served as a negative control. In 
human spleen few 4-1BB positive cells were found, fewer than in earlier 
specimens, which could indicate preparation problems. When comparing cytospin 
specimens no significant differences in 4-1BB protein expression were seen 
between Lad-2 cells incubated for zero hours in serum free medium and Lad-2 
cells incubated for four respective twenty-four hours in serum free medium 
conditioned with Kat-4 cells. Lad-2 cells incubated for twenty-four hours in serum 
free medium with calcium ionophore had more positive cells than Lad-2 cells 
incubated for zero hours in serum free medium (Figure 7). Some moderately 
positive cells, i. e. cells expressing 4-1BB, were found in Lad-2 cells incubated 
for twenty-four hours in serum free medium with calcium ionophore. This 
indicates that mast cells can express the protein, which also was shown by 
Nishimoto et al. in 2005. In this study no expression of 4-1BB protein is seen in 
HMC-1 cells or Lad-2 cells incubated in tumor conditioned medium. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. A. Human spleen incubated with rabbit anti-4-1BB mAb. Few positive cells, 
black arrow. B. Lad-2 cells incubated for zero hours in serum free medium conditioned 
with Kat-4 cells, cytospin specimen incubated with rabbit anti-4-1BB mAb. No distinctly 
positive cells are found. C. Lad-2 cells incubated for twenty-four hours in serum free 
medium with calcium ionophore, cytospin specimen incubated with rabbit anti-4-1BB 
mAb. Some moderately positive cells, black arrows, are found. D. Lad-2 cells incubated 
for twenty-four hours in serum free medium conditioned with Kat-4 cells, cytospin 
specimen incubated with rabbit anti-4-1BB mAb. No distinctly positive cells are found. 
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DISCUSSION 
In the first FACS experiment (Figure 3), performed with cell surface staining, no 
expression of 4-1BB was detected in HMC-1 cells incubated with tumor 
conditioned medium. By using this method even a low protein expression should 
be found. If there is no technical problem or problem with the preparations it is 
reasonable to assume that human mast cells do not express 4-1BB on their cell 
surface. If they express the protein intracellularly that can be discovered by using 
an intracellular staining in the next FACS experiment. The next FACS experiment 
was therefore performed with intracellular staining. In that experiment Lad-2 cells 
was used instead of HMC-1 cells since they are more like peripheral mast cells.  
In the first immunohistology experiment (Figure 4), no expression of 4-1BB was 
seen in HMC-1 cells incubated in medium conditioned with Kat-4 cells. A study 
showed that 4-1BB is expressed on the cell surface of T cells (Yunle et al., 2003). 
In human spleen 4-1BB was expressed in some cells and the rabbit anti-4-1BB 
pAb was shown to work. There were cells with a high expression of 4-1BB, cells 
with a quiet low expression of 4-1BB and cells with no expression of 4-1BB. The 
rabbit Ig pAb did not work, which made it hard to find the specific expression of 
4-1BB. There can be several reasons for these problems, for example with the 
antibodies, the preparations and with the HMC-1 cells. Therefore, the next 
immunohistology experiment was carried with Lad-2 cells, since they are more 
like peripheral mast cells.   
In the second FACS experiment (Figure 5), carried out with intracellular staining, 
no expression of 4-1BB was detected in Lad-2 cells incubated in medium 
conditioned with SK-MEL-30. Since neither HMC-1 cells nor Lad-2 cells showed 
an expression of 4-1BB mRNA it was not reasonable to expect a protein 
expression of 4-1BB. The shift in expression of 4-1BB in Lad-2 cells incubated 
for twenty-four hours in serum free medium with calcium ionophore indicates that 
mast cells can be induced to express the protein, which also was shown by 
Nishimoto et al. in 2005. The Fc-block, used to block unspecific binding, was 
manufactured for use on mouse cells and not human cells. Probably it does not 
work on human cells. To optimize this method, the Fc-block should be changed 
into one that is manufactured for use on human cells. It would then be interesting 
to perform a FACS experiment, carried out with cell surface staining, using Lad-2 
cells incubated in medium conditioned with Kat-4 cells. If that does not work, an 
experiment with intracellular staining of Lad-2 cells conditioned with Kat-4 cells 
can be performed.  
In the first Real time-PCR experiment (Figure 6A), an up-regulation of 4-1BB 
was seen after four hours in HMC-1 cells incubated in medium conditioned with 
Kat-4 cells. This indicates that human mast cells can express 4-1BB. In the second 
Real time-PCR experiment (Figure 6 B), there seemed to be a serum effect on 
Lad-2 cells expressing 4-1BB both when they were stimulated with or without 
medium conditioned with SK-MEL-30 cells.  
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The use of a positive control, Lad-2 cells incubated in serum free medium with 
calcium ionophore, showed that human mast cells can induce the expression of 4-
1BB. These two results together led to the third real time-PCR experiment (Figure 
6C), where Lad-2 cells incubated in serum free medium conditioned with Kat-4 
cells showed a significant up-regulation of 4-1BB after four hours. After twenty-
four hours, gene expression decreased. A study showed that mast cells sensitized 
with IgE over night have an up-regulated gene expression of 4-1BB (Nishimoto et 
al., 2005). The same study showed that mast cell protein expression of 4-1BB 
reaches its highest levels after 8 hours sensitization with IgE and after 12 hours 
the expression is reduced. Further, it was shown that the level of 4-1BB decreased 
during the incubation time if no more stimulation was done. That result is similar 
to this study’s result, where Lad-2 cells incubated in serum free medium 
conditioned with Kat-4 cells up-regulate 4-1BB after four hours and start to 
reduce the expression within twenty-four hours. Mast cells incubated with 
calcium ionophore have an increased gene expression after twenty-four hours 
compared to the expression after four hours. In this study I show that neither 
HMC-1 cells nor Lad-2 cells incubated with SK-MEL-30 conditioned medium up-
regulate their gene expression of 4-1BB. That does not mean an up-regulation of 
4-1BB is impossible to find in other cell lines. It is interesting that mast cells 
accumulate around melanomas (Guidolin et al., 2005) especially since anti-4-1BB 
mAb is in stage II clinical trials for treatment of melanomas (U.S. National 
institutes of health. [online], 2010). Guidolin et. al., 2005 showed that mast cells 
may be of importance for tumor angiogenesis and thereby promote tumor 
development. If mast cells have the ability to inhibit some stage of tumor 
development is still an open question.  
In the second immunohistology experiment (Figure 7), no expression of 4-1BB 
protein was seen in Lad-2 cells incubated in serum free medium conditioned with 
Kat-4 cells. In Lad-2 cells incubated for twenty-four hours in serum free medium 
with calcium ionophore, some cells had a moderate expression of 4-1BB. This 
indicates that mast cells can express the protein, which also was shown by 
Nishimoto et al. in 2005. In this study, no protein expression of 4-1BB has been 
registered, neither in HMC-1 cells nor in Lad-2 cells incubated in medium 
conditioned with Kat-4 cells. A reason for this can be that the rabbit anti-4-1BB 
pAb does not work properly, e.g if it is too unspecific. Another cause can be 
problems with the fixation of the cytospin specimens. Since the gene expression 
of 4-1BB is quite low in Lad-2 cells incubated in serum medium conditioned with 
Kat-4 cells, the protein expression can also be low. This method probably needs a 
certain rate of expression to find to the protein and, if that rate is to low, that can 
be the reason for not observing any expression of 4-1BB. Lad-2 cells incubated in 
serum medium with calcium ionophore, which has a much higher rate of gene 
expression of 4-1BB, shows some moderately positive cells. The cytospin 
specimens with mast cells incubated with rabbit IgG pAb are overexposed since 
the antibody does not work properly. A probable reason was insufficient dilution 
of the antibody, which can cause high unspecific binding of the antibody. This 
antibody was not prepared by the same manufacturer or in the same way as the 
rabbit anti-4-1BB pAb. This can be the reason why it does not work as expected.  
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The rabbit anti-4-1BB pAb seems to work, it works in the positive control, and 
therefore the reason for it not working in the cytospin specimens should be 
determined. The fixation procedure and the rate of expression of 4-1BB differ 
between the positive control and the cytospin specimens. Since the rate of 
expression cannot be manipulated, the fixation procedure for the cytospin 
specimens may be of particular interest.  
My results show that in the human mast cell models I used it was possible to 
detect increased mRNA levels of 4-1BB when the mast cells where incubated in 
tumor conditioned medium. However, it was not possible to prove a connection 
between gene expression and increased expression of 4-1BB protein in mast cells 
exposed to tumor factors. If there are no technical reasons for the difference it is 
an additional example of the known fact that mRNA and protein expression is not 
always directly correlated. More studies are required to resolve if my results are a 
general phenomenon or if they are dependent on the cell models.  
 
 
  
  
 
 
 
20 
ACKNOWLEDGEMENTS 
I want to thank my supervisor Helena Wensman, my co-supervisor Gunnar Pejler 
as well as the rest of the staff at the Section of Biochemistry at the Department for 
Anatomy, Physiology and Biochemistry. 
This study was performed without any animal experiments. 
  
  
 
 
 
21 
REFERENCES 
Carlini, M. J., Dalurzo, M. C. L., Lastiri, J. M., Smith, D. E., Vasallo, B. C., Puricelli, L. 
I. and de Cidre L. S. L. (2010). Mast cell phenotypes and microvessels in non–small 
cell lung cancer and its prognostic significance. Human Pathology 41, 697–705.  
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O.,  
Werb, Z.,  Caughey, G. H. and Hanahan, D. (1999). Inflammatory mast cells up-
regulate angiogenesis during squamous epithelial carcinogenesis. Genes and 
development 13, 1382–1397.  
Grewal, I. S. (Ed.). (2009). Therapeutic Targets of the TNF Superfamily. New York: 
Springer Science and Business Media, LLC Landes Bioscience 
Guidolin, D., Crivellato, E., Nico, B., Andreis, P. G., Nussdorfer G. G. and Ribatti D. 
(2006). An image analysis of the spatial distribution of perivascular mast cells in 
human melanoma. International journal of molecular medicine 17, 981-987. 
Guhl, S., Babina, M., Neou, A., Zuberbier, T. and Artuc, M. (2010). Experimental 
Dermatology 19, 845–847. Mast cell lines HMC-1 and LAD2 in comparison with 
mature human skin mast cells – drastically reduced levels of tryptase and chymase in 
mast cell lines. 
Husmark, J., Heldin, N.E. and Nilsson, M. (2002). Follicular growth of a thyroid 
carcinoma cell line (KAT-4) with abnormal E-cadherin and impaired epithelial 
barrier. Thyroid 12 (9), 781-790. 
Kwon, B. S. and Weissman, S. M. (1989). cDNA sequences of two inducible T-cell genes. 
Proc. Natl. Acad. Sci. 86, 1963-1967. 
Lu, X., Jiang, X., Liu, R., Zhao, H. and Liang, Z. (2008). Adoptive transfer of pTRP2-
specific CTLs expanding by bead-based artificial antigen-presenting cells mediates 
anti-melanoma response. Cancer Letters 271, 129–139. 
Lu, X-L., Jiang, X-B., Liu, R-E. and Zhang, S-M. (2009). In vivo anti-melanoma eYcacy 
of allo-restricted CTLs specific for melanoma expanded by artificial antigen-
presenting cells. Cancer Immunol Immunother 58, 629–638. 
Maltby, S., Khazaie, K. and McNagny, K. M. (2009). Mast cells in tumor growth: 
Angiogenesis, tissue remodelling and immune-modulation. Biochimica et Biophysica 
Acta 1796, 19–26. 
Miller, R. E., Jones, J., Le, T., Whitmore, J., Boiani, N., Gliniak, B. and Lynch D. H. 
(2002). 4-1BB-Specific Monoclonal Antibody Promotes the Generation of Tumor-
Specific Immune Responses by Direct Activation of CD8 T Cells in a CD40-
Dependent Manner. J Immunol 169, 1792-1800. 
Molecular station. Home page. Available from: http://www.molecularstation.com/real-
time-pcr/#realtimeintro, 2010-11-25 
Murillo, O., Arina, A., Hervas-Stubbs, S., Gupta, A., McCluskey, B., Dubrot, J., Palazón, 
A., Azpilikueta, A., Ochoa, M. C., Alfaro, C., Solano, S., Pérez-Gracia, J. L.,Oyajobi, 
B. O. and Melero, I. (2008). Therapeutic anti-tumor efficacy of anti-CD137 agonistic 
monoclonal antibody in mouse models of myeloma. Clin Cancer Res. Author 
manuscript; available in PMC 2009 November 1. 
  
  
 
 
 
22 
Nishimoto, H., Lee, S-W., Hong, H., Potter, K. G., Maeda-Yamamoto, M., Kinoshita, T., 
Kawakami, Y., Mittler, R. S., Kwon, B. S., Ware, C. F., Croft, M. and Kawakami, T. 
(2005) Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor 
receptor superfamily, with the high-affinity IgE receptor. Blood J. 106(13), 4twenty-
four1-4twenty-four8. 
Oldford, S. A., Haidl, I. D., Howatt, M. A., Leiva, C. A., Johnston, B. and Marshall, J. S. 
(2010). A Critical Role for Mast Cells and Mast Cell-Derived IL-6 in TLR2-Mediated 
Inhibition of Tumor Growth. J. Immunol. 185, 7067-7076.  
Ribatti, D., Guidolin, D., Marzullo, A., Nico, B., Annese, T., Benagiano, V. and 
Crivellato, E. (2010). Mast cells and angiogenesis in gastric carcinoma. Int. J. Exp. 
Path.  
Romano, P., Manniello, A., Aresu, O., Armento, M., Cesaro, M., Parodi, B (2009). Cell 
Line Data Base: structure and recent improvements towards molecular 
authentication of human cell lines. Nucleic Acids Research 37(Database issue):D925-
D932. DOI: doi:10.1093/nar/gkn730; PMID: 18927105 
Sawatsubashi, M., Yamada, T., Fukushima, N., Mizokami, H., Tokunaga, O. and Shin, T. 
(2000). Association of vascular endothelial growth factor and mast cells with 
angiogenesis in laryngeal squamous cell carcinoma. Virchows Arch. 436, twenty-
four3–twenty-four8. 
Schwarz, H. (2005). Biological activities of reverse signal transduction throughCD137 
ligand. J. Leukoc. Biol. 77, 281-286. 
Soucek, L., Lawlor, E. R., Soto, D., Shchors, K., Brown Swigart, L. and Evan G. I. 
(2007). Mast cells are required for angiogenesis and macroscopic expansion of Myc-
induced pancreatic islet tumors. Nature medicine 13 (10), 1211-1218. 
U.S. National institutes of health. [online] (2010-12-02). Available from: 
http://clinicaltrials.gov/ct2/show/study/NCT00612664?show_locs=Y#locn [2011-01-
02] 
Xiang, M., Gu, Y., Zhao, F., Lu, H., Chen, S. and Yin, L. (2010). Mast cell tryptase 
promotes breast cancer migration and invasion. Oncol. reports 23, 615-619.  
Yoshii, M., Jikuhara, A., Mori, S., Iwagaki, H., Takahashi, H. K., Nishibori, M. and 
Tanaka N. (2005). Mast Cell Tryptase Stimulates DLD-1 Carcinoma Through 
Prostaglandinand MAP Kinase-Dependent Manners. J Pharmacol Sci 98, 450 – 458. 
Yunle, W., Shusen, Z., Changku, J., Jiayin, Y., Xiaoling, J. and Zhicheng, Z. (2003). 4-
1BB gene expression in peripheral blood mononuclear cells from orthotopic liver 
transplant recipients with graft acceptance. Chinese Medical Journal 116 (12), 1854-
1859.  
